Germ-killing caps on dialysis catheters to prevent infections
Part of Infections clinical trials.
This study tests whether putting a small cap containing chlorhexidine (a germ-killing medicine) on the end of the dialysis catheter can prevent serious bloodstream infections. If you are on dialysis with a catheter, this may help reduce your risk of infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have kidney failure and be getting dialysis through a catheter (a small tube) placed in a large vein.
- You must not have had a bloodstream infection within the past 21 days.
- You must not be allergic to chlorhexidine, nylon, or polypropylene.
- You must be able to give informed consent, and not have cognitive impairments or be on end-of-life care.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a liquid that is put into the dialysis catheter after each session to prevent infections that can happen through the catheter. It is designed for children up to age 18 who need hemodialysis through a catheter.
This study tests different ways to secure and care for central lines (special tubes that deliver medicine or fluids) to reduce infections and improve comfort. It may help find the best method for each patient.
This trial tests whether using a special antiseptic solution (Irrisept) when removing a urinary catheter can lower the chance of getting a urinary tract infection. It is for people visiting a urology clinic for catheter removal who are not already on antibiotics.
This study looks at ways to better treat central line infections that are hard to cure because of bacteria that stick to the tube. It may help find a treatment that works better for patients in intensive care.
This study looks at the bacteria that can build up on IV lines to see if they increase the risk of infection. By examining these bacteria, researchers hope to find ways to reduce infections in patients who need IV treatment.
This trial tests a new type of dialysis catheter that may stay working longer and cause fewer problems. It compares this new catheter to standard catheters used in the past, and it is for adults who need hemodialysis.
Hear when a new Vascular Access Complication trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.